Immunogen reported $0 in Loan Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Abbvie ABBV:US $ 63522M 667M
Agios Pharmaceuticals AGIO:US $ 0.28M 0M
Amgen AMGN:US $ 36010M 2788M
Astellas Pharma 4503:JP Y 95886M 105648M
AstraZeneca AZN:LN 28805M 83M
Bluebird Bio BLUE:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 37450M 2155M
Cerulean Pharma CERU:US $ 0 0
Eli Lilly And LLY:US $ 15152.9M 193.5M
Emergent Biosolutions EBS:US $ 801.5M 7.9M
Exelixis EXEL:US $ 0M 0M
Halozyme Therapeutics HALO:US $ 788.1M 0.84M
Heron Therapeutics HRTX:US $ 149.13M 0.05M
Immunogen IMGN:US $ 0M 0M
Intrexon XON:US $ 201.11M 18.36M
Karyopharm Therapeutics KPTI:US $ 302.49M 198K
Macrogenics MGNX:US $ 0 0
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NVS:US $ 24373M 150M
Pfizer PFE:US $ 35656M 539M
Regeneron Pharmaceuticals REGN:US $ 2700.4M 720.4M
Seattle Genetics SGEN:US $ 0M 0M